On January 2, 2018, Calmare Therapeutics Incorporated filed a preliminary consent revocation statement soliciting proxies and urged the shareholders to mark the “yes, revoke my consent” on the Company’s consent revocation card for the (1) removal of Conrad Mir, Peter Brennan, Rustin Howard, and Carl O’Connell as directors of the Company and (2) election of the following 5 nominees: Stanley Yarbro, Robert Conway, Steve Roehrich, Robert Davis, and Benjamin Large as directors of the Company.